phenylbutazone has been researched along with acenocoumarol in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (41.67) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortijo, J; Gálvez, J; García-Domenech, R; Morcillo, E; Ríos-Santamarina, I; Santamaria, P | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
d' Athis, P; Tillement, JP; Vassent, G; Zini, R | 1 |
Lecompte, F; Renaud, S | 1 |
Kragh-Hansen, U; Maruyama, T; Otagiri, M; Yamasaki, K | 1 |
GUGGISBERG, W; MONTIGEL, C | 1 |
DAYTON, PG; WEINER, M | 1 |
ADL, M; GORTVAI, G; KOVACS, M | 1 |
12 other study(ies) available for phenylbutazone and acenocoumarol
Article | Year |
---|---|
New bronchodilators selected by molecular topology.
Topics: Animals; Bronchodilator Agents; Discriminant Analysis; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Structure-Activity Relationship; Trachea | 1998 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.
Topics: Acenocoumarol; Binding Sites; Butyrates; Carbon Radioisotopes; Dialysis; Humans; Kinetics; Mathematics; Pharmaceutical Preparations; Phenylbutazone; Protein Binding; Serum Albumin; Ultrafiltration; Warfarin | 1974 |
Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats.
Topics: Acenocoumarol; Adenine Nucleotides; Aniline Compounds; Animals; Anticoagulants; Blood Coagulation; Blood Platelets; Drug Synergism; Endotoxins; Hyperlipidemias; Oxyphenbutazone; Phenylacetates; Phenylbutazone; Platelet Adhesiveness; Rats; Sulfinpyrazone; Thrombin; Thrombosis | 1970 |
Characterization of site I on human serum albumin: concept about the structure of a drug binding site.
Topics: Acenocoumarol; Anticoagulants; Asparagine; Benzocaine; Binding Sites; Binding, Competitive; Dansyl Compounds; Fluorescent Dyes; Humans; Iodipamide; Phenylbutazone; Serum Albumin; Warfarin | 1996 |
[Experience with butazolidin-sintrom combined prevention & butazolidine prevention Of thromboembolic disease].
Topics: Acenocoumarol; Anticoagulants; Coumarins; Phenylbutazone; Thromboembolism | 1958 |
DRUG-INDUCED INCREASE OF PROTHROMBIN COMPLEX ACTIVITY IN VIVO.
Topics: Acenocoumarol; Aminopyrine; Animals; Antipyrine; Blood Coagulation Factors; Blood Coagulation Tests; Guinea Pigs; Hematologic Tests; Pharmacology; Phenylbutazone; Prothrombin; Prothrombin Time; Research | 1964 |
[OUR EXPERIENCES WITH LASTING ANTICOAGULANT THERAPY].
Topics: Acenocoumarol; Aminopyrine; Anticoagulants; Blood Pressure Determination; Heparin; Intracranial Embolism; Intracranial Embolism and Thrombosis; Liver Function Tests; Myocardial Infarction; Phenylbutazone; Prothrombin Time; Pulmonary Embolism; Thrombophlebitis; Thrombosis; Toxicology | 1964 |